Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study.
Autor: | Reed S; Berlin Center for Epidemiology and Health Research (ZEG), Berlin, Germany., Koro C; Merck & Co., Inc, North Wales, PA, USA., DiBello J; Merck & Co., Inc, North Wales, PA, USA., Becker K; Berlin Center for Epidemiology and Health Research (ZEG), Berlin, Germany., Bauerfeind A; Berlin Center for Epidemiology and Health Research (ZEG), Berlin, Germany., Franke C; Berlin Center for Epidemiology and Health Research (ZEG), Berlin, Germany., Heinemann K; Berlin Center for Epidemiology and Health Research (ZEG), Berlin, Germany. |
---|---|
Jazyk: | angličtina |
Zdroj: | The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception [Eur J Contracept Reprod Health Care] 2021 Dec; Vol. 26 (6), pp. 447-453. Date of Electronic Publication: 2021 Oct 15. |
DOI: | 10.1080/13625187.2021.1988923 |
Abstrakt: | Objective: To assess and compare the risk of unintended pregnancy in NOMAC-E2 users with levonorgestrel-containing COC (COC Study Design: In this observational study, new users 1 of NOMAC-E2 and COC Results: Overall, 44,559 and 46,754 users were recruited to the NOMAC-E2 and COC Conclusions: NOMAC-E2 demonstrated superior contraceptive effectiveness compared to COC |
Databáze: | MEDLINE |
Externí odkaz: |